Effect of autologous hematopoietic stem cell transplant on the development of second primary malignancies in multiple myeloma patients
Abstract Autologous stem cell transplant (aHSCT) is associated with improved survival for multiple myeloma (MM) patients but may be associated with second primary malignancy (SPM) development. Using the California Cancer Registry linked to statewide hospitalization data, we determined the cumulative...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-01-01
|
Series: | Blood Cancer Journal |
Online Access: | https://doi.org/10.1038/s41408-020-00400-4 |